Interference between human hepatitis A virus and an attenuated apathogenic avian virus

Area of Science:

• Virology
• Immunology
• Hepatology

Background:

• Human hepatitis A virus (HAV) infection causes significant liver disease.
• Viral interference is a phenomenon where one virus inhibits another's replication.
• Exploring non-pathogenic viruses for therapeutic intervention against pathogenic viruses is an emerging area.

Purpose of the Study:

• To investigate the therapeutic potential of an attenuated apathogenic avian bursa virus (ABV) against human hepatitis A virus (HAV) infection.
• To determine if ABV superinfection could alter the clinical and pathological course of HAV infection in a primate model.

Main Methods:

• Marmoset monkeys were inoculated with human HAV.
• Following HAV inoculation, monkeys were superinfected with attenuated ABV at one and three weeks.
• Control groups received HAV only.
• Serum glutamic pyruvic transaminase (SGPT) levels and liver histopathology were assessed.

Main Results:

• Superinfected monkeys showed no significant SGPT elevation or pathological liver changes characteristic of hepatitis.
• Control animals exhibited marked SGPT elevation (six times higher) and histopathological evidence of hepatitis.
• This represents the first documented instance of a nonpathogenic virus interfering with a pathogenic human virus.

Conclusions:

• Attenuated apathogenic ABV demonstrated a definite interference effect against human HAV infection in marmosets.
• This study supports the feasibility of using nonpathogenic viruses as a therapeutic strategy for virus-induced diseases.
• Further research into viral interference holds promise for novel antiviral therapies.